BRITTANY CASTILLO: Open Payments
NPI 1033659412 · METAIRIE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,007 in 58 payments from 8 companies in 2025. Trend: 2023 $125 · 2024 $1,194 · 2025 $2,007
Food & beverage: $2,007
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 11 | $448 |
| Teva Pharmaceuticals USA, Inc. | 14 | $441 |
| E.R. Squibb & Sons, L.L.C. | 10 | $314 |
| Janssen Pharmaceuticals, Inc | 4 | $267 |
| Neurocrine BioSciences, Inc. | 10 | $265 |
| Edwards Lifesciences Corporation | 1 | $125 |
| Otsuka America Pharmaceutical, Inc. | 4 | $82 |
| Lundbeck LLC | 4 | $65 |
Products named: UZEDY, COBENFY, LYBALVI, INGREZZA, ARISTADA, SPRAVATO, INVEGA, ABILIFY ASIMTUFII.
Industry payments across LA — which companies pay providers there.
